Form 4 for TECH Bio-Techne
Accepted 2025-08-19 00:00:00 ET · period of report 2025-08-15 · accession 0001062993-25-014700 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-19 | 2025-08-15 | TECH | Kelderman Kim | CEO, Dir | F - Tax | $53.60 | -4,305 | 51.0K | -8% | -$230.7K |
| D | 2025-08-19 | 2025-08-15 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | +8,543 | 55.3K | +18% | $0 |
| D | 2025-08-19 | 2025-08-15 | TECH | Kelderman Kim | CEO, Dir | M - OptEx | $0.00 | -8,543 | 17.1K | -33% | $0 |
| DM | 2025-08-19 | 2025-08-15 | TECH | Kelderman Kim | CEO, Dir | A - Grant | $0.00 | +196.5K | 35.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-15 | F | D | 4,305 | $53.60 | 50,968 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-15 | M | A | 8,543 | $0.00 | 55,273 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2025-08-15 | M | D | 8,543 | $0.00 | 17,087 | D | — · — to — | 8,543 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F8) 8,543 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. |
| 4 | Derivative | Performance Restricted Stock Units | 2025-08-15 | A | A | 70,708 | $0.00 | 70,708 | D | — · — to — | 70,708 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F10) Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
| 5 | Derivative | Stock Options (Right to Buy) | 2025-08-15 | A | A | 90,441 | $0.00 | 90,441 | D | $53.60 · — to 2035-08-15 | 90,441 Common Stock | (F12) Options to purchase 30,147 shares vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. |
| 6 | Derivative | Restricted Stock Units | 2025-08-15 | A | A | 35,354 | $0.00 | 35,354 | D | — · — to — | 35,354 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F11) 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. |